These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25300964)

  • 1. Pathophysiology, diagnosis, and management of hepatic encephalopathy.
    Sheasgreen C; Lu L; Patel A
    Inflammopharmacology; 2014 Dec; 22(6):319-26. PubMed ID: 25300964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Haj M; Rockey DC
    Am J Gastroenterol; 2020 May; 115(5):723-728. PubMed ID: 31658104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic encephalopathy. Physiopathology and treatment].
    Perney P; Pomier-Layrargues G
    Gastroenterol Clin Biol; 1994; 18(12):1069-76. PubMed ID: 7750679
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia.
    Rahimi RS; Rockey DC
    Semin Liver Dis; 2016 Feb; 36(1):48-55. PubMed ID: 26870932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
    Luo M; Guo JY; Cao WK
    World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of hepatic encephalopathy in cirrhosis.
    Romero-Gómez M
    Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
    Gerber T; Schomerus H
    Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emergency treatment of hepatic coma and porto-caval encephalopathy].
    Imler M
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Encephalopathy: Current and Emerging Treatment Modalities.
    Fallahzadeh MA; Rahimi RS
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8S):S9-S19. PubMed ID: 35940731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic encephalopathy.
    Khungar V; Poordad F
    Clin Liver Dis; 2012 May; 16(2):301-20. PubMed ID: 22541700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present-day therapy of hepatic encephalopathy (author's transl)].
    Imler M
    MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatic encephalopathy after portal shunt in the patient with cirrhosis].
    Grange D; Bismuth H
    Arch Fr Mal App Dig; 1975; 64(3):257-69. PubMed ID: 1108827
    [No Abstract]   [Full Text] [Related]  

  • 19. Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments.
    Eriksen PL; Djernes L; Vilstrup H; Ott P
    J Hepatol; 2023 Aug; 79(2):340-348. PubMed ID: 37061198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Alsahhar JS; Rahimi RS
    Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.